117th Congress (2021–2023) · House bill · Sponsor: Rep. DeLauro, Rosa L. [D-CT-3]
This page covers HR7790 in the 117th Congress. Bill numbers start over every Congress, so HR7790 in another Congress is a different bill.
| Item | Detail |
|---|---|
| Roll-call votes | 2 |
| Chamber | House |
| Latest vote | 2022-05-18: Passed |
| Latest action | 2022-05-19: Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 374. |
| Policy area | Agriculture and Food |
| Official record | Congress.gov |
Infant Formula Supplemental Appropriations Act, 2022 This bill provides $28 million in emergency supplemental appropriations to address the shortage of infant formula in the United States. Specifically, the bill provides appropriations for the Food and Drug Administration (FDA) to (1) address the current shortage of FDA-regulated infant formula and certain medical foods in the United States; and (2) prevent future shortages, including by taking the steps that are necessary to prevent fraudulent products from entering the U. S. market.
Subjects: Appropriations, Child health, Congressional oversight, Department of Health and Human Services, Executive agency funding and structure, Food and Drug Administration (FDA), Food supply, safety, and labeling, Fraud offenses and financial crimes, Nutrition and diet, Trade restrictions
Every recorded vote on this bill, newest first, with a link to the official tally. Member-by-member positions are on each member’s profile.
| Date | Chamber | Question | Result | Yea | Nay | Not voting | Record |
|---|---|---|---|---|---|---|---|
| 2022-05-18 | House | Yea-and-Nay | Passed | 152 | 139 | 4 | Official tally |
| 2022-05-18 | House | Yea-and-Nay | Failed | 143 | 147 | 5 | Official tally |
HR7790 (Infant Formula Supplemental Appropriations Act, 2022) was introduced in the 117th Congress (2021–2023) by Rep. DeLauro, Rosa L. [D-CT-3].
On 2022-05-19: Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 374.
2 recorded votes in the 117th Congress. The most recent, on 2022-05-18, was "Yea-and-Nay": Passed.